Summary
September 2006, Vol. 3, No. 5, Pages 563-571 , DOI 10.1517/17425247.3.5.563

pH-responsive shielding of non-viral gene vectors

Martin Meyer1 & Ernst Wagner2
1PhD Student, Pharmaceutical Biology–Biotechnology, Department of Pharmacy, Ludwig-Maximilians-Universität, Butenandtstrasse 5-13, D-81377 Munich, Germany
2Professor and Chairman of Pharmaceutical Biology–Biotechnology, Pharmaceutical Biology–Biotechnology, Department of Pharmacy, Ludwig-Maximilians-Universität, Butenandtstrasse 5-13, D-81377 Munich, Germany.
Author for correspondence



PEG shielding of non-viral vectors reduces undesired interactions with the extracellular environment. Combination with cell-binding domains enables in vivo targeting via specific attachment to the target cells. Pegylation, however, also interferes with effective intracellular nucleic acid delivery. Consistently triggered removal of the PEG shield after reaching the target cell would make non-viral vectors more compatible with the intracellular delivery steps. Physiological triggers may include changes in pH, enzyme concentration or redox potential. This review focuses on pH-sensitive shielding strategies that exploit the endosomal acidification process after endocytosis for deshielding of the delivery system.

Full Text | PDF (139 KB) | PDF Plus (233 KB)

Forward Links to Citing Articles

Ernst Wagner. (2007) Programmed drug delivery: nanosystems for tumor targeting. Expert Opinion on Biological Therapy 7:5, 587-593
Online publication date: 1-May-2007.
Summary | Full Text | PDF (395 KB) | PDF Plus (391 KB) 

Users who read this article also read:

Linear cyclodextrin-containing polymers and their use as delivery agents
Jeremy D Heidel
Expert Opinion on Drug Delivery, Sep 2006, Vol. 3, No. 5, Pages 641-646.
Summary | Full Text | PDF (84 KB) | PDF Plus (134 KB) | Add to Favorites | Related 
Time-controlled oral delivery systems for colon targeting
Andrea Gazzaniga, Alessandra Maroni, Maria Edvige Sangalli, Lucia Zema
Expert Opinion on Drug Delivery, Sep 2006, Vol. 3, No. 5, Pages 583-597.
Summary | Full Text | PDF (174 KB) | PDF Plus (305 KB) | Add to Favorites | Related 
Microfabricated nanochannel implantable drug delivery devices: trends, limitations and possibilities
Phyllis Gardner
Expert Opinion on Drug Delivery, Jul 2006, Vol. 3, No. 4, Pages 479-487.
Summary | Full Text | PDF (256 KB) | PDF Plus (348 KB) | Add to Favorites | Related 
Sublingual immunotherapy of allergic diseases
Melanie Werner-Klein, Frank Kalkbrenner, Klaus J Erb
Expert Opinion on Drug Delivery, Sep 2006, Vol. 3, No. 5, Pages 599-612.
Summary | Full Text | PDF (302 KB) | PDF Plus (394 KB) | Add to Favorites | Related 
Chemical modification and formulation approaches to elevated drug transport across cell membranes
Soumyajit Majumdar, Ashim K Mitra
Expert Opinion on Drug Delivery, Jul 2006, Vol. 3, No. 4, Pages 511-527.
Summary | Full Text | PDF (182 KB) | PDF Plus (437 KB) | Add to Favorites | Related 
Drug delivery strategies using polysaccharidic gels
Tommasina Coviello, Pietro Matricardi, Franco Alhaique
Expert Opinion on Drug Delivery, May 2006, Vol. 3, No. 3, Pages 395-404.
Summary | Full Text | PDF (221 KB) | PDF Plus (363 KB) | Add to Favorites | Related 
 

Prev. Article | Next Article
View/Print PDF (139 KB)
View PDF Plus (233 KB)
Add to favourite
Email to a friend
TOC Alert | Citation Alert What is RSS?

 
 
Quick Search
for 
Authors:
Martin Meyer
Ernst Wagner
Keywords:
artificial viruses
bioresponsive
non-viral gene transfer
PEG shielding
smart delivery systems